Stay updated on Milademetan Safety in AML/MDS Clinical Trial

Sign up to get notified when there's something new on the Milademetan Safety in AML/MDS Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Milademetan Safety in AML/MDS Clinical Trial page

  1. Check
    today
    Change Detected
    Summary
    The footer revision identifier changed from v3.7.2 to v3.8.0; the study record remains inaccessible behind a 403 error.
    Difference
    0.2%
    Check dated 2026-11-02T03:19:10.000Z thumbnail image
  2. Check
    7 days ago
    Change Detected
    Summary
    A site-wide NIH notice announces updates and FAQs about the transition from “Artificial Intelligence” to “Super Intelligence” terminology.
    Difference
    1%
    Check dated 2026-10-26T04:47:52.000Z thumbnail image
  3. Check
    14 days ago
    Change Detected
    Summary
    The footer revision identifier changes from v3.7.1 to v3.7.2 on the 403 error page.
    Difference
    0.2%
    Check dated 2026-10-19T06:54:38.000Z thumbnail image
  4. Check
    21 days ago
    Change Detected
    Summary
    The footer’s ClinicalTrials.gov revision identifier changes from v3.7.0 to v3.7.1.
    Difference
    0.2%
    Check dated 2026-10-12T07:36:15.000Z thumbnail image
  5. Check
    42 days ago
    Change Detected
    Summary
    The study page now shows a 403 error, replacing the previous detailed study content with an access-denied message. The change removes the rich study data and presents an error state instead.
    Difference
    21%
    Check dated 2026-09-21T01:02:15.000Z thumbnail image
  6. Check
    64 days ago
    Change Detected
    Summary
    The page now shows Revision: v3.6.6, replacing the previous v3.6.5. This indicates a website/software update rather than any modification to the study content.
    Difference
    0.0%
    Check dated 2026-08-30T22:30:58.000Z thumbnail image

Stay in the know with updates to Milademetan Safety in AML/MDS Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Milademetan Safety in AML/MDS Clinical Trial page.